Quris-AI’s Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation


Quris-AI to Provide Safety Assessments for Small Molecule Drug Candidates Before Initiating Clinical Trials Quris-AI to Provide Safety Assessments for Small Molecule Drug Candidates Before Initiating Clinical Trials

See original here:
Quris-AI's Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation

Related Posts